Collplant Biotechnologies Stock Buy Hold or Sell Recommendation
| CLGN Stock | USD 5.41 0.01 0.19% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Collplant Biotechnologies is 'Strong Sell'. Macroaxis provides Collplant Biotechnologies buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CLGN positions. The advice algorithm takes into account all of Collplant Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Collplant Biotechnologies' buy or sell advice are summarized below:
Real Value 8.05 | Target Price 16.92 | Hype Value 5.4 | Market Value 5.41 | Naive Value 5.47 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Collplant Biotechnologies given historical horizon and risk tolerance towards Collplant Biotechnologies. When Macroaxis issues a 'buy' or 'sell' recommendation for Collplant Biotechnologies, the advice is generated through an automated system that utilizes algorithms and statistical models.
Collplant |
Execute Collplant Biotechnologies Buy or Sell Advice
The Collplant recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Collplant Biotechnologies. Macroaxis does not own or have any residual interests in Collplant Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Collplant Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Collplant Biotechnologies Trading Alerts and Improvement Suggestions
| The company reported the previous year's revenue of 10.96 M. Net Loss for the year was (7.02 M) with profit before overhead, payroll, taxes, and interest of 13.64 M. | |
| Collplant Biotechnologies currently holds about 36.29 M in cash with (2.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.27. | |
| Collplant Biotechnologies has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: CollPlant Biotechnologies Is In A Strong Position To Grow Its Business |
Collplant Biotechnologies Returns Distribution Density
The distribution of Collplant Biotechnologies' historical returns is an attempt to chart the uncertainty of Collplant Biotechnologies' future price movements. The chart of the probability distribution of Collplant Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Collplant Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Collplant Biotechnologies returns is essential to provide solid investment advice for Collplant Biotechnologies.
| Mean Return | 0.07 | Value At Risk | -4.96 | Potential Upside | 5.43 | Standard Deviation | 2.86 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Collplant Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Collplant Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Collplant Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Collplant Biotechnologies backward and forwards among themselves. Collplant Biotechnologies' institutional investor refers to the entity that pools money to purchase Collplant Biotechnologies' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Parallel Advisors, Llc | 2023-12-31 | 71.0 |
Collplant Biotechnologies Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (1.7M) | (445K) | 9.8M | 16.5M | (2.8M) | (2.6M) | |
| Free Cash Flow | (7.2M) | (5.0M) | 912K | (15.0M) | (3.7M) | (3.9M) | |
| Depreciation | 539K | 660K | 773K | 1.1M | 1.1M | 556.9K | |
| Other Non Cash Items | 3.6M | 173K | (28K) | 521K | 3.8M | 3.9M | |
| Capital Expenditures | 1.5M | 519K | 1.6M | 1.3M | 954K | 698.2K | |
| Net Income | (11.2M) | (5.8M) | 237K | (16.9M) | (7.0M) | (7.4M) | |
| End Period Cash Flow | 4.0M | 3.5M | 13.4M | 29.9M | 26.9M | 28.3M | |
| Change To Inventory | (74K) | (374K) | 181K | (312K) | 749K | 786.5K | |
| Investments | (1.5M) | (519K) | (30M) | 28.9M | (1.1M) | (1.1M) | |
| Change To Netincome | 4.7M | 1.8M | 1.3M | 2.7M | 3.1M | 2.8M |
Collplant Biotechnologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Collplant Biotechnologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Collplant Biotechnologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Collplant stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.05 | |
β | Beta against NYSE Composite | 0.07 | |
σ | Overall volatility | 2.82 | |
Ir | Information ratio | -0.0094 |
Collplant Biotechnologies Volatility Alert
Collplant Biotechnologies currently demonstrates below-average downside deviation. It has Information Ratio of -0.01 and Jensen Alpha of 0.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Collplant Biotechnologies' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Collplant Biotechnologies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Collplant Biotechnologies Fundamentals Vs Peers
Comparing Collplant Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Collplant Biotechnologies' direct or indirect competition across all of the common fundamentals between Collplant Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Collplant Biotechnologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Collplant Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Collplant Biotechnologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Collplant Biotechnologies to competition |
| Fundamentals | Collplant Biotechnologies | Peer Average |
| Return On Equity | -0.23 | -0.31 |
| Return On Asset | -0.13 | -0.14 |
| Profit Margin | (0.64) % | (1.27) % |
| Operating Margin | (16.95) % | (5.51) % |
| Current Valuation | 36.73 M | 16.62 B |
| Shares Outstanding | 11.45 M | 571.82 M |
| Shares Owned By Insiders | 10.10 % | 10.09 % |
| Shares Owned By Institutions | 12.23 % | 39.21 % |
| Number Of Shares Shorted | 10.83 K | 4.71 M |
| Price To Earning | 92.60 X | 28.72 X |
| Price To Book | 2.12 X | 9.51 X |
| Price To Sales | 5.48 X | 11.42 X |
| Revenue | 10.96 M | 9.43 B |
| Gross Profit | 13.64 M | 27.38 B |
| EBITDA | (6.41 M) | 3.9 B |
| Net Income | (7.02 M) | 570.98 M |
| Cash And Equivalents | 36.29 M | 2.7 B |
| Cash Per Share | 3.27 X | 5.01 X |
| Total Debt | 3.16 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 16.21 X | 2.16 X |
| Book Value Per Share | 2.48 X | 1.93 K |
| Cash Flow From Operations | (2.76 M) | 971.22 M |
| Short Ratio | 1.29 X | 4.00 X |
| Earnings Per Share | (0.62) X | 3.12 X |
| Target Price | 11.0 | |
| Number Of Employees | 75 | 18.84 K |
| Beta | 0.41 | -0.15 |
| Market Capitalization | 61.85 M | 19.03 B |
| Total Asset | 34.13 M | 29.47 B |
| Retained Earnings | (96.74 M) | 9.33 B |
| Working Capital | 24.77 M | 1.48 B |
| Current Asset | 17.03 M | 9.34 B |
Collplant Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Collplant . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 1.92 | |||
| Daily Balance Of Power | 1.0 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 5.42 | |||
| Day Typical Price | 5.41 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 51.48 |
About Collplant Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Collplant Biotechnologies? Buying financial instruments such as Collplant Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1.4M | 1.4M | 1.6M | 1.0M | Total Assets | 51.2M | 37.8M | 34.1M | 18.2M |
Use Investing Ideas to Build Portfolios
In addition to having Collplant Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Coal Thematic Idea Now
Coal
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 12 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Collplant Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.Note that the Collplant Biotechnologies information on this page should be used as a complementary analysis to other Collplant Biotechnologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Collplant Stock analysis
When running Collplant Biotechnologies' price analysis, check to measure Collplant Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collplant Biotechnologies is operating at the current time. Most of Collplant Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Collplant Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collplant Biotechnologies' price. Additionally, you may evaluate how the addition of Collplant Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Collplant Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.962 | Quarterly Revenue Growth 4.155 | Return On Assets (0.13) | Return On Equity (0.23) |
The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.